Study of the paraoxonase and platelet-activating factor acetylhydrolase activities with aging
- 1 November 2001
- journal article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 65 (5-6) , 241-246
- https://doi.org/10.1054/plef.2001.0320
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1 192 or PON1 55 GenotypeArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- THE OLDER MAN'S HEART AND HEART DISEASEMedical Clinics of North America, 1999
- Serum Paraoxonase After Myocardial InfarctionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Age-related development of atherosclerotic plaque stress: a population-based finite-element analysisCoronary Artery Disease, 1998
- Low Density Lipoprotein Oxidation and Its Pathobiological SignificanceJournal of Biological Chemistry, 1997
- Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.Journal of Clinical Investigation, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997
- Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetesThe Lancet, 1995
- HDL, its enzymes and its potential to influence lipid peroxidationAtherosclerosis, 1995
- Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbitNature, 1985